1 Spine Osteoarthritis Pain Medicine Market Overview 1.1 Spine Osteoarthritis Pain Medicine Product Overview 1.2 Spine Osteoarthritis Pain Medicine Market Segment by Type 1.2.1 Oral 1.2.2 Injection 1.2.3 External 1.3 Global Spine Osteoarthritis Pain Medicine Market Size by Type 1.3.1 Global Spine Osteoarthritis Pain Medicine Market Size Overview by Type (2016-2027) 1.3.2 Global Spine Osteoarthritis Pain Medicine Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Spine Osteoarthritis Pain Medicine Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Spine Osteoarthritis Pain Medicine Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Spine Osteoarthritis Pain Medicine Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Spine Osteoarthritis Pain Medicine Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Spine Osteoarthritis Pain Medicine Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Spine Osteoarthritis Pain Medicine Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Spine Osteoarthritis Pain Medicine Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Spine Osteoarthritis Pain Medicine Sales Breakdown by Type (2016-2021) 1.4.2 Europe Spine Osteoarthritis Pain Medicine Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Spine Osteoarthritis Pain Medicine Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Spine Osteoarthritis Pain Medicine Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Breakdown by Type (2016-2021) 2 Global Spine Osteoarthritis Pain Medicine Market Competition by Company 2.1 Global Top Players by Spine Osteoarthritis Pain Medicine Sales (2016-2021) 2.2 Global Top Players by Spine Osteoarthritis Pain Medicine Revenue (2016-2021) 2.3 Global Top Players Spine Osteoarthritis Pain Medicine Price (2016-2021) 2.4 Global Top Manufacturers Spine Osteoarthritis Pain Medicine Manufacturing Base Distribution, Sales Area, Product Type 2.5 Spine Osteoarthritis Pain Medicine Market Competitive Situation and Trends 2.5.1 Spine Osteoarthritis Pain Medicine Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Spine Osteoarthritis Pain Medicine Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Spine Osteoarthritis Pain Medicine as of 2020) 2.7 Date of Key Manufacturers Enter into Spine Osteoarthritis Pain Medicine Market 2.8 Key Manufacturers Spine Osteoarthritis Pain Medicine Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Spine Osteoarthritis Pain Medicine Status and Outlook by Region 3.1 Global Spine Osteoarthritis Pain Medicine Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Spine Osteoarthritis Pain Medicine Historic Market Size by Region 3.2.1 Global Spine Osteoarthritis Pain Medicine Sales in Volume by Region (2016-2021) 3.2.2 Global Spine Osteoarthritis Pain Medicine Sales in Value by Region (2016-2021) 3.2.3 Global Spine Osteoarthritis Pain Medicine Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Spine Osteoarthritis Pain Medicine Forecasted Market Size by Region 3.3.1 Global Spine Osteoarthritis Pain Medicine Sales in Volume by Region (2022-2027) 3.3.2 Global Spine Osteoarthritis Pain Medicine Sales in Value by Region (2022-2027) 3.3.3 Global Spine Osteoarthritis Pain Medicine Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Spine Osteoarthritis Pain Medicine by Application 4.1 Spine Osteoarthritis Pain Medicine Market Segment by Application 4.1.1 Medical Care 4.1.2 Personal Care 4.2 Global Spine Osteoarthritis Pain Medicine Market Size by Application 4.2.1 Global Spine Osteoarthritis Pain Medicine Market Size Overview by Application (2016-2027) 4.2.2 Global Spine Osteoarthritis Pain Medicine Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Spine Osteoarthritis Pain Medicine Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Spine Osteoarthritis Pain Medicine Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Spine Osteoarthritis Pain Medicine Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Spine Osteoarthritis Pain Medicine Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Spine Osteoarthritis Pain Medicine Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Spine Osteoarthritis Pain Medicine Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Spine Osteoarthritis Pain Medicine Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Spine Osteoarthritis Pain Medicine Sales Breakdown by Application (2016-2021) 4.3.2 Europe Spine Osteoarthritis Pain Medicine Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Spine Osteoarthritis Pain Medicine Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Spine Osteoarthritis Pain Medicine Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Breakdown by Application (2016-2021) 5 North America Spine Osteoarthritis Pain Medicine by Country 5.1 North America Spine Osteoarthritis Pain Medicine Historic Market Size by Country 5.1.1 North America Spine Osteoarthritis Pain Medicine Sales in Volume by Country (2016-2021) 5.1.2 North America Spine Osteoarthritis Pain Medicine Sales in Value by Country (2016-2021) 5.2 North America Spine Osteoarthritis Pain Medicine Forecasted Market Size by Country 5.2.1 North America Spine Osteoarthritis Pain Medicine Sales in Volume by Country (2022-2027) 5.2.2 North America Spine Osteoarthritis Pain Medicine Sales in Value by Country (2022-2027) 6 Europe Spine Osteoarthritis Pain Medicine by Country 6.1 Europe Spine Osteoarthritis Pain Medicine Historic Market Size by Country 6.1.1 Europe Spine Osteoarthritis Pain Medicine Sales in Volume by Country (2016-2021) 6.1.2 Europe Spine Osteoarthritis Pain Medicine Sales in Value by Country (2016-2021) 6.2 Europe Spine Osteoarthritis Pain Medicine Forecasted Market Size by Country 6.2.1 Europe Spine Osteoarthritis Pain Medicine Sales in Volume by Country (2022-2027) 6.2.2 Europe Spine Osteoarthritis Pain Medicine Sales in Value by Country (2022-2027) 7 Asia-Pacific Spine Osteoarthritis Pain Medicine by Region 7.1 Asia-Pacific Spine Osteoarthritis Pain Medicine Historic Market Size by Region 7.1.1 Asia-Pacific Spine Osteoarthritis Pain Medicine Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Spine Osteoarthritis Pain Medicine Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Spine Osteoarthritis Pain Medicine Forecasted Market Size by Region 7.2.1 Asia-Pacific Spine Osteoarthritis Pain Medicine Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Spine Osteoarthritis Pain Medicine Sales in Value by Region (2022-2027) 8 Latin America Spine Osteoarthritis Pain Medicine by Country 8.1 Latin America Spine Osteoarthritis Pain Medicine Historic Market Size by Country 8.1.1 Latin America Spine Osteoarthritis Pain Medicine Sales in Volume by Country (2016-2021) 8.1.2 Latin America Spine Osteoarthritis Pain Medicine Sales in Value by Country (2016-2021) 8.2 Latin America Spine Osteoarthritis Pain Medicine Forecasted Market Size by Country 8.2.1 Latin America Spine Osteoarthritis Pain Medicine Sales in Volume by Country (2022-2027) 8.2.2 Latin America Spine Osteoarthritis Pain Medicine Sales in Value by Country (2022-2027) 9 Middle East and Africa Spine Osteoarthritis Pain Medicine by Country 9.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Historic Market Size by Country 9.1.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Spine Osteoarthritis Pain Medicine Forecasted Market Size by Country 9.2.1 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Spine Osteoarthritis Pain Medicine Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Spine Osteoarthritis Pain Medicine Business 10.1 Pfizer 10.1.1 Pfizer Corporation Information 10.1.2 Pfizer Introduction and Business Overview 10.1.3 Pfizer Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Pfizer Spine Osteoarthritis Pain Medicine Products Offered 10.1.5 Pfizer Recent Development 10.2 Johnson and Johnson 10.2.1 Johnson and Johnson Corporation Information 10.2.2 Johnson and Johnson Introduction and Business Overview 10.2.3 Johnson and Johnson Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Pfizer Spine Osteoarthritis Pain Medicine Products Offered 10.2.5 Johnson and Johnson Recent Development 10.3 GlaxoSmithKline 10.3.1 GlaxoSmithKline Corporation Information 10.3.2 GlaxoSmithKline Introduction and Business Overview 10.3.3 GlaxoSmithKline Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.3.4 GlaxoSmithKline Spine Osteoarthritis Pain Medicine Products Offered 10.3.5 GlaxoSmithKline Recent Development 10.4 Bayer 10.4.1 Bayer Corporation Information 10.4.2 Bayer Introduction and Business Overview 10.4.3 Bayer Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Bayer Spine Osteoarthritis Pain Medicine Products Offered 10.4.5 Bayer Recent Development 10.5 Eli Lilly 10.5.1 Eli Lilly Corporation Information 10.5.2 Eli Lilly Introduction and Business Overview 10.5.3 Eli Lilly Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Eli Lilly Spine Osteoarthritis Pain Medicine Products Offered 10.5.5 Eli Lilly Recent Development 10.6 Novartis 10.6.1 Novartis Corporation Information 10.6.2 Novartis Introduction and Business Overview 10.6.3 Novartis Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Novartis Spine Osteoarthritis Pain Medicine Products Offered 10.6.5 Novartis Recent Development 10.7 Sanofi 10.7.1 Sanofi Corporation Information 10.7.2 Sanofi Introduction and Business Overview 10.7.3 Sanofi Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Sanofi Spine Osteoarthritis Pain Medicine Products Offered 10.7.5 Sanofi Recent Development 10.8 Horizon Pharma 10.8.1 Horizon Pharma Corporation Information 10.8.2 Horizon Pharma Introduction and Business Overview 10.8.3 Horizon Pharma Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Horizon Pharma Spine Osteoarthritis Pain Medicine Products Offered 10.8.5 Horizon Pharma Recent Development 10.9 Abbott 10.9.1 Abbott Corporation Information 10.9.2 Abbott Introduction and Business Overview 10.9.3 Abbott Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Abbott Spine Osteoarthritis Pain Medicine Products Offered 10.9.5 Abbott Recent Development 10.10 Mylan 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Spine Osteoarthritis Pain Medicine Product Category, Application and Specification 10.10.3 Mylan Spine Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 Mylan Recent Development 10.11 Daiichi Sankyo 10.11.1 Daiichi Sankyo Corporation Information 10.11.2 Daiichi Sankyo Introduction and Business Overview 10.11.3 Daiichi Sankyo Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Daiichi Sankyo Spine Osteoarthritis Pain Medicine Products Offered 10.11.5 Daiichi Sankyo Recent Development 10.12 TEVA 10.12.1 TEVA Corporation Information 10.12.2 TEVA Introduction and Business Overview 10.12.3 TEVA Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.12.4 TEVA Spine Osteoarthritis Pain Medicine Products Offered 10.12.5 TEVA Recent Development 10.13 Almatica Pharma 10.13.1 Almatica Pharma Corporation Information 10.13.2 Almatica Pharma Introduction and Business Overview 10.13.3 Almatica Pharma Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Almatica Pharma Spine Osteoarthritis Pain Medicine Products Offered 10.13.5 Almatica Pharma Recent Development 10.14 Astellas Pharma 10.14.1 Astellas Pharma Corporation Information 10.14.2 Astellas Pharma Introduction and Business Overview 10.14.3 Astellas Pharma Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.14.4 Astellas Pharma Spine Osteoarthritis Pain Medicine Products Offered 10.14.5 Astellas Pharma Recent Development 10.15 Tide Pharmaceutical 10.15.1 Tide Pharmaceutical Corporation Information 10.15.2 Tide Pharmaceutical Introduction and Business Overview 10.15.3 Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.15.4 Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Products Offered 10.15.5 Tide Pharmaceutical Recent Development 10.16 Iroko Pharmaceuticals 10.16.1 Iroko Pharmaceuticals Corporation Information 10.16.2 Iroko Pharmaceuticals Introduction and Business Overview 10.16.3 Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.16.4 Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Products Offered 10.16.5 Iroko Pharmaceuticals Recent Development 10.17 Hengrui Pharmaceutical 10.17.1 Hengrui Pharmaceutical Corporation Information 10.17.2 Hengrui Pharmaceutical Introduction and Business Overview 10.17.3 Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.17.4 Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Products Offered 10.17.5 Hengrui Pharmaceutical Recent Development 10.18 Abiogen Pharma 10.18.1 Abiogen Pharma Corporation Information 10.18.2 Abiogen Pharma Introduction and Business Overview 10.18.3 Abiogen Pharma Spine Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 10.18.4 Abiogen Pharma Spine Osteoarthritis Pain Medicine Products Offered 10.18.5 Abiogen Pharma Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Spine Osteoarthritis Pain Medicine Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Spine Osteoarthritis Pain Medicine Industrial Chain Analysis 11.4 Spine Osteoarthritis Pain Medicine Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Spine Osteoarthritis Pain Medicine Distributors 12.3 Spine Osteoarthritis Pain Medicine Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Major Company of External Table 4. Global Spine Osteoarthritis Pain Medicine Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Spine Osteoarthritis Pain Medicine Sales by Type (2016-2021) & (K Units) Table 6. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Type (2016-2021) Table 7. Global Spine Osteoarthritis Pain Medicine Sales by Type (2016-2021) & (US& Million) Table 8. Global Spine Osteoarthritis Pain Medicine Market Share in Value by Type (2016-2021) Table 9. Global Spine Osteoarthritis Pain Medicine Price by Type (2016-2021) & (USD/Unit) Table 10. Global Spine Osteoarthritis Pain Medicine Sales by Type (2022-2027) & (K Units) Table 11. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Type (2022-2027) Table 12. Global Spine Osteoarthritis Pain Medicine Sales by Type (2022-2027) & (US$ Million) Table 13. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Type (2022-2027) Table 14. Global Spine Osteoarthritis Pain Medicine Price by Type (2022-2027) & (USD/Unit) Table 15. North America Spine Osteoarthritis Pain Medicine Sales by Type (2016-2021) & (K Units) Table 16. North America Spine Osteoarthritis Pain Medicine Sales by Type (2016-2021) & (US$ Million) Table 17. Europe Spine Osteoarthritis Pain Medicine Sales (K Units) by Type (2016-2021) Table 18. Europe Spine Osteoarthritis Pain Medicine Sales by Type (2016-2021) & (US$ Million) Table 19. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales (K Units) by Type (2016-2021) Table 20. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales by Type (2016-2021) & (US$ Million) Table 21. Latin America Spine Osteoarthritis Pain Medicine Sales (K Units) by Type (2016-2021) Table 22. Latin America Spine Osteoarthritis Pain Medicine Sales by Type (2016-2021) & (US$ Million) Table 23. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales (K Units) by Type (2016-2021) Table 24. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Type (2016-2021) & (US$ Million) Table 25. Global Spine Osteoarthritis Pain Medicine Sales by Company (2016-2021) & (K Units) Table 26. Global Spine Osteoarthritis Pain Medicine Sales Share by Company (2016-2021) Table 27. Global Spine Osteoarthritis Pain Medicine Revenue by Company (2016-2021) & (US$ Million) Table 28. Global Spine Osteoarthritis Pain Medicine Revenue Share by Company (2016-2021) Table 29. Global Market Spine Osteoarthritis Pain Medicine Price by Company (2016-2021) & (USD/Unit) Table 30. Global Spine Osteoarthritis Pain Medicine Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Spine Osteoarthritis Pain Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Spine Osteoarthritis Pain Medicine as of 2020 Table 33. Date of Key Manufacturers Enter into Spine Osteoarthritis Pain Medicine Market Table 34. Key Manufacturers Spine Osteoarthritis Pain Medicine Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Spine Osteoarthritis Pain Medicine Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 37. Global Spine Osteoarthritis Pain Medicine Sales by Region (2016-2021) & (K Units) Table 38. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Region (2016-2021) Table 39. Global Spine Osteoarthritis Pain Medicine Sales by Region (2016-2021) & (US$ Million) Table 40. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Region (2016-2021) Table 41. Global Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 42. Global Spine Osteoarthritis Pain Medicine Sales by Region (2022-2027) & (K Units) Table 43. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Region (2022-2027) Table 44. Global Spine Osteoarthritis Pain Medicine Sales by Region (2022-2027) & (US$ Million) Table 45. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Region (2022-2027) Table 46. Global Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2022-2027) Table 47. Global Spine Osteoarthritis Pain Medicine Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 48. Global Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) & (K Units) Table 49. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Application (2016-2021) Table 50. Global Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) & (US$ Million) Table 51. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application (2016-2021) Table 52. Global Spine Osteoarthritis Pain Medicine Price by Application (2016-2021) & (USD/Unit) Table 53. Global Spine Osteoarthritis Pain Medicine Sales by Application (2022-2027) & (K Units) Table 54. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Application (2022-2027) Table 55. Global Spine Osteoarthritis Pain Medicine Sales by Application (2022-2027) & (US$ Million) Table 56. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application (2022-2027) Table 57. Global Spine Osteoarthritis Pain Medicine Price by Application (2022-2027) & (USD/Unit) Table 58. North America Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) (K Units) Table 59. North America Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) & (US$ Million) Table 60. North America Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application in 2020 Table 61. Europe Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) (K Units) Table 62. Europe Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) & (US$ Million) Table 63. Europe Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application in 2020 Table 64. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) (K Units) Table 65. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) & (US$ Million) Table 66. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application in 2020 Table 67. Latin America Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) (K Units) Table 68. Latin America Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) & (US$ Million) Table 69. Latin America Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application in 2020 Table 70. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) (K Units) Table 71. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Application (2016-2021) & (US$ Million) Table 72. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application in 2020 Table 73. North America Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 74. North America Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Country (2016-2021) Table 75. North America Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (US$ Million) Table 76. North America Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Country (2016-2021) Table 77. North America Spine Osteoarthritis Pain Medicine Sales by Country (2022-2027) & (K Units) Table 78. North America Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Country (2022-2027) Table 79. North America Spine Osteoarthritis Pain Medicine Sales by Country (2022-2027) & (US$ Million) Table 80. North America Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Country (2022-2027) Table 81. Europe Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 82. Europe Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Country (2016-2021) Table 83. Europe Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (US$ Million) Table 84. Europe Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Country (2016-2021) Table 85. Europe Spine Osteoarthritis Pain Medicine Sales by Country (2022-2027) & (K Units) Table 86. Europe Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Country (2022-2027) Table 87. Europe Spine Osteoarthritis Pain Medicine Sales by Country (2022-2027) & (US$ Million) Table 88. Europe Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Country (2022-2027) Table 89. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales by Region (2016-2021) & (K Units) Table 90. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Region (2016-2021) Table 91. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales by Region (2016-2021) & (US$ Million) Table 92. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Region (2016-2021) Table 93. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales by Region (2022-2027) & (K Units) Table 94. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Region (2022-2027) Table 95. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales by Region (2022-2027) & (US$ Million) Table 96. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Region (2022-2027) Table 97. Latin America Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 98. Latin America Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Country (2016-2021) Table 99. Latin America Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (US$ Million) Table 100. Latin America Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Country (2016-2021) Table 101. Latin America Spine Osteoarthritis Pain Medicine Sales by Country (2022-2027) & (K Units) Table 102. Latin America Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Country (2022-2027) Table 103. Latin America Spine Osteoarthritis Pain Medicine Sales by Country (2022-2027) & (US$ Million) Table 104. Latin America Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Country (2022-2027) Table 105. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 106. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Country (2016-2021) Table 107. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Country (2016-2021) Table 109. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Country (2022-2027) & (K Units) Table 110. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Country (2022-2027) Table 111. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales by Country (2022-2027) & (US$ Million) Table 112. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Country (2022-2027) Table 113. Pfizer Corporation Information Table 114. Pfizer Introduction and Business Overview Table 115. Pfizer Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Pfizer Spine Osteoarthritis Pain Medicine Product Table 117. Pfizer Recent Development Table 118. Johnson and Johnson Corporation Information Table 119. Johnson and Johnson Introduction and Business Overview Table 120. Johnson and Johnson Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Johnson and Johnson Spine Osteoarthritis Pain Medicine Product Table 122. Johnson and Johnson Recent Development Table 123. GlaxoSmithKline Corporation Information Table 124. GlaxoSmithKline Introduction and Business Overview Table 125. GlaxoSmithKline Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. GlaxoSmithKline Spine Osteoarthritis Pain Medicine Product Table 127. GlaxoSmithKline Recent Development Table 128. Bayer Corporation Information Table 129. Bayer Introduction and Business Overview Table 130. Bayer Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. Bayer Spine Osteoarthritis Pain Medicine Product Table 132. Bayer Recent Development Table 133. Eli Lilly Corporation Information Table 134. Eli Lilly Introduction and Business Overview Table 135. Eli Lilly Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. Eli Lilly Spine Osteoarthritis Pain Medicine Product Table 137. Eli Lilly Recent Development Table 138. Novartis Corporation Information Table 139. Novartis Introduction and Business Overview Table 140. Novartis Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 141. Novartis Spine Osteoarthritis Pain Medicine Product Table 142. Novartis Recent Development Table 143. Sanofi Corporation Information Table 144. Sanofi Introduction and Business Overview Table 145. Sanofi Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 146. Sanofi Spine Osteoarthritis Pain Medicine Product Table 147. Sanofi Recent Development Table 148. Horizon Pharma Corporation Information Table 149. Horizon Pharma Introduction and Business Overview Table 150. Horizon Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 151. Horizon Pharma Spine Osteoarthritis Pain Medicine Product Table 152. Horizon Pharma Recent Development Table 153. Abbott Corporation Information Table 154. Abbott Introduction and Business Overview Table 155. Abbott Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 156. Abbott Spine Osteoarthritis Pain Medicine Product Table 157. Abbott Recent Development Table 158. Mylan Corporation Information Table 159. Mylan Introduction and Business Overview Table 160. Mylan Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 161. Mylan Spine Osteoarthritis Pain Medicine Product Table 162. Mylan Recent Development Table 163. Daiichi Sankyo Corporation Information Table 164. Daiichi Sankyo Introduction and Business Overview Table 165. Daiichi Sankyo Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 166. Daiichi Sankyo Spine Osteoarthritis Pain Medicine Product Table 167. Daiichi Sankyo Recent Development Table 168. TEVA Corporation Information Table 169. TEVA Introduction and Business Overview Table 170. TEVA Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 171. TEVA Spine Osteoarthritis Pain Medicine Product Table 172. TEVA Recent Development Table 173. Almatica Pharma Corporation Information Table 174. Almatica Pharma Introduction and Business Overview Table 175. Almatica Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 176. Almatica Pharma Spine Osteoarthritis Pain Medicine Product Table 177. Almatica Pharma Recent Development Table 178. Astellas Pharma Corporation Information Table 179. Astellas Pharma Introduction and Business Overview Table 180. Astellas Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 181. Astellas Pharma Spine Osteoarthritis Pain Medicine Product Table 182. Astellas Pharma Recent Development Table 183. Tide Pharmaceutical Corporation Information Table 184. Tide Pharmaceutical Introduction and Business Overview Table 185. Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 186. Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Product Table 187. Tide Pharmaceutical Recent Development Table 188. Iroko Pharmaceuticals Corporation Information Table 189. Iroko Pharmaceuticals Introduction and Business Overview Table 190. Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 191. Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Product Table 192. Iroko Pharmaceuticals Recent Development Table 193. Hengrui Pharmaceutical Corporation Information Table 194. Hengrui Pharmaceutical Introduction and Business Overview Table 195. Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 196. Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Product Table 197. Hengrui Pharmaceutical Recent Development Table 198. Abiogen Pharma Corporation Information Table 199. Abiogen Pharma Introduction and Business Overview Table 200. Abiogen Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 201. Abiogen Pharma Spine Osteoarthritis Pain Medicine Product Table 202. Abiogen Pharma Recent Development Table 203. Key Raw Materials Lists Table 204. Raw Materials Key Suppliers Lists Table 205. Spine Osteoarthritis Pain Medicine Market Trends Table 206. Spine Osteoarthritis Pain Medicine Market Drivers Table 207. Spine Osteoarthritis Pain Medicine Market Challenges Table 208. Spine Osteoarthritis Pain Medicine Market Restraints Table 209. Spine Osteoarthritis Pain Medicine Distributors List Table 210. Spine Osteoarthritis Pain Medicine Downstream Customers Table 211. Research Programs/Design for This Report Table 212. Key Data Information from Secondary Sources Table 213. Key Data Information from Primary Sources List of Figures Figure 1. Spine Osteoarthritis Pain Medicine Product Picture Figure 2. Global Spine Osteoarthritis Pain Medicine Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Spine Osteoarthritis Pain Medicine Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Spine Osteoarthritis Pain Medicine Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of Oral Figure 6. Global Oral Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of Injection Figure 8. Global Injection Sales YoY Growth (2016-2021) & (K Units) Figure 9. Product Picture of External Figure 10. Global External Sales YoY Growth (2016-2021) & (K Units) Figure 11. Global Spine Osteoarthritis Pain Medicine Sales by Type (2016-2027) & (US$ Million) Figure 12. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Type (2016-2021) Figure 13. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Type (2016-2021) Figure 14. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Type (2022-2027) Figure 15. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Type (2022-2027) Figure 16. North America Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Type in 2020 Figure 17. North America Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Type in 2020 Figure 18. Europe Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Type in 2020 Figure 19. Europe Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Type in 2020 Figure 20. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Type in 2020 Figure 21. Asia-Pacific Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Type in 2020 Figure 22. Latin America Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Type in 2020 Figure 23. Latin America Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Type in 2020 Figure 24. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Type in 2020 Figure 25. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Type in 2020 Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Spine Osteoarthritis Pain Medicine Sales in 2020 Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Spine Osteoarthritis Pain Medicine Revenue in 2020 Figure 28. Spine Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Product Picture of Medical Care Figure 30. Global Medical Care Sales YoY Growth (2016-2027) & (K Units) Figure 31. Product Picture of Personal Care Figure 32. Global Personal Care Sales YoY Growth (2016-2027) & (K Units) Figure 33. Global Spine Osteoarthritis Pain Medicine Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application (2016-2021) Figure 36. Global Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Spine Osteoarthritis Pain Medicine Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Spine Osteoarthritis Pain Medicine Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Spine Osteoarthritis Pain Medicine Manufacturing Cost Structure Figure 42. Spine Osteoarthritis Pain Medicine Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Pfizer Johnson and Johnson GlaxoSmithKline Bayer Eli Lilly Novartis Sanofi Horizon Pharma Abbott Mylan Daiichi Sankyo TEVA Almatica Pharma Astellas Pharma Tide Pharmaceutical Iroko Pharmaceuticals Hengrui Pharmaceutical Abiogen Pharma